Stocks and Investing
Stocks and Investing
Tue, April 9, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, April 8, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Samantha Semenkow Maintained (TSVT) at Strong Buy with Increased Target to $12 on, Apr 8th, 2024
Samantha Semenkow of Citigroup, Maintained "2seventy bio, Inc." (TSVT) at Strong Buy with Increased Target from $9 to $12 on, Apr 8th, 2024.
Samantha has made no other calls on TSVT in the last 4 months.
There are 3 other peers that have a rating on TSVT. Out of the 3 peers that are also analyzing TSVT, 2 agree with Samantha's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- David Nierengarten of "Wedbush" Reiterated at Hold and Held Target at $5 on, Monday, March 18th, 2024
- Yaron Werber of "TD Cowen" Downgraded from Buy to Hold on, Wednesday, January 31st, 2024
This is the rating of the analyst that currently disagrees with Samantha
- Daina Graybosch of "Leerink Partners" Upgraded from Hold to Buy and Increased Target to $18 on, Wednesday, January 31st, 2024
Contributing Sources